Aktie A3CQ6J MYND LIFE SCIENCES INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen MYND Life Sciences Inc.

Aktien

A3CQ6J

CA62857B1094

MYND

Markt geschlossen - Canadian Securities Exchange
Andere Börsenplätze
 21:09:47 30.04.2024 		% 5 Tage % 1. Jan.
0,035 CAD +16,67 % Intraday Chart für MYND Life Sciences Inc. +16,67 % -12,50 %
21.03. MYND Life Sciences Inc. meldet Ergebnis für das erste Quartal bis zum 31. Januar 2024 CI
04.03. MYND Life Sciences Inc. meldet Ergebnis für das am 31. Oktober 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023
MYND Life Sciences Inc. Appoints Laurie Bakke as an Independent Non-Executive Director
MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. to Executive Chairman from the Role of CEO
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. from the Role of CEO to Executive Chairman
MYND Life Sciences Inc. Appoints Mr. John Campbell as Chief Executive Officer
MYND Life Sciences Inc. Appoints John Campbell as President
MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer
Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences
MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc.
MYND Life Sciences Inc. entered into a non-binding letter of intent to acquire Cava Healthcare Inc.
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023
MYND Life Sciences Inc. Auditor Raises 'Going Concern' Doubt
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2022
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022
VMYND Lifesciencs Inc. cancelled the acquisition of Tidal Psychedelics.
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3CQ6J Aktie
  4. Nachrichten MYND Life Sciences Inc.
  5. Andere Sprachen